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Abstract
Background: Avian influenza virus H5N1 is a major concern as a potential global pandemic. It is
thought that multiple key events must take place before efficient human-to-human transmission of
the virus occurs. The first step in overcoming host restriction is viral entry which is mediated by
HA, responsible for both viral attachment and viral/host membrane fusion. HA binds to glycans-
containing receptors with terminal sialic acid (SA). It has been shown that avian influenza viruses
preferentially bind to α2,3-linked SAs, while human influenza A viruses exhibit a preference for
α2,6-linked SAs. Thus it is believed the precise linkage of SAs on the target cells dictate host
tropism of the viruses.
Results: We demonstrate that H5N1 HA/HIV pseudovirus can efficiently transduce several human
cell lines including human lung cells. Interestingly, using a lectin binding assay we show that the
presence of both α2,6-linked and α2,3-linked SAs on the target cells does not always correlate with
efficient transduction. Further, HA substitutions of the residues implicated in switching SA-binding
between avian and human species did not drastically affect HA-mediated transduction of the target
cells or target cell binding.
Conclusion: Our results suggest that a host factor(s), which is yet to be identified, is required for
H5N1 entry in the host cells.
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Background
H5N1 is an avian influenza virus which originally circu-
lated in aquatic birds without causing major disease.
However, a rapidly spreading variant(s) of H5N1 is highly
pathogenic to avian species, causing a major economic
loss due to culling of millions of potentially infected birds
[1-5]. Alarmingly, this virus has crossed the species barrier
to cause numerous human (and other animal) fatalities in
certain regions of Asia, Europe and Africa[6,7]. The
unprecedented spread and the high mortality rate of this
virus have raised a major concern for a potential global
pandemic. The lack of effective vaccines for humans and
the emergence of oseltamivir-resistant H5N1 strains[8,9]
underscore the urgent need in developing novel prophy-
lactic and therapeutic treatments against this virus.
Influenza virus is an enveloped, negative-stranded, and
segmented RNA virus. Two viral glycoproteins, hemagglu-
tinin (HA) and neuraminidase (NA), on the viral surface,
determine antigenic subtypes. Although the role of NA in
the influenza life cycle is not clear, one of its functions is
to release the progeny viral particles from the cell surface
during budding. In contrast, the roles of the prototypic
HA in viral entry have been well characterized by molecu-
lar, biochemical, biophysical, and structural techniques.
HA is synthesized as a precursor, HA0, that forms trimers
in the endoplasmic reticulum (ER). This precursor is
cleaved into two subunits, HA1 and HA2, which are linked
by a disulfide bond[10]. Many HAs contain a consensus
sequence R-X-R/K-R as the cleavage site recognized by
host furin-like proteases[11]. The presence of this polyba-
sic motif in HA has been shown to correlate with the high
pathogenicity of influenza viruses[3,10,12-14].
The two subunits of HA perform distinct functions in viral
entry. HA2 mediates membrane fusion and viral entry,
while HA1 is involved in binding to the sialic acid (SA)
receptors on the target cells[10]. Comparison of the HA1
and HA2  sequences among influenza virus subtypes
reveals that the HA2 sequence is well conserved, suggest-
ing a highly conserved membrane fusion mechanism.
However, the HA1 sequence is much more divergent, sug-
gesting differences in affinity of receptor-binding and in
antigenicity. Although HA1 binds to SA with a low affinity,
it is believed that interaction of multiple HA molecules on
the viral surface with the SA-containing glycoproteins or
glycolipids on the cell surface increases the avidity of
influenza virus to the target cells[15], and this interaction
facilitates viral infection through endocytosis in a pH-
dependent manner.
Although bird flu H5N1 is a highly contagious pathogen
in avian species, its transmission to humans, or more
rarely human-to-human transmission, has been very lim-
ited thus far[6]. A more transmissible and sustained vari-
ant(s) of H5N1 in human populations may arise through
accumulating mutations in multiple viral proteins of
H5N1 and/or genomic reassortment between H5N1 and
other influenza viruses[12]. An outbreak of a highly path-
ogenic H5N1 influenza virus in migratory birds of several
species in Qinghai Lake, China was reported
recently[16,17]. It was feared then and realized now that
the H5N1-infected migratory birds could carry and trans-
mit the virus to avian and non-avian animals including
humans in densely populated areas on different conti-
nents[18]. In this study, we characterized several aspects
of the host cell tropism of H5N1, and our results implicate
an unidentified host factor in H5N1 entry.
Results
H5N1 HA can mediate HIV pseudoviral infection
To alleviate the safety concerns in characterizing the entry
mechanism of highly pathogenic avian influenza virus
H5N1, we sought to develop an human immunodefi-
ciency virus (HIV)-based entry assay, a surrogate system
widely used for entry studies of other highly pathogenic
enveloped viruses such as Ebola virus [19-22]. To generate
the HIV pseudovirions, a mammalian expression vector
pcDNA-3 containing the hemagglutinin (HA) gene which
was derived from a highly pathogenic H5N1 from dead
birds in Qinghai Lake, China[16], referred to as HA(QH)
in this report, was co-transfected with an env-deficient
HIV vector, pNL4-3-Luc-R--E- [23], in 293T producer cells.
Western blotting analysis of the media collected from the
293T cells 48-hours post-transfection indicated that
HA(QH) was efficiently incorporated into the HIV viral
particles (data not shown). To test if the HA(QH)/HIV
pseudovirions could infect target cells, four cell lines,
293T (human), HeLa (human), QT6 (quail), and DF-1
(chicken), were incubated with the pseudovirions or con-
trol pseudovirions, and the luciferase activities of the chal-
lenged cells were determined 48 hours post-infection and
presented as relative luciferase units, or RLUs, in Fig. 1A.
The cells incubated with the HIV virions without any viral
glycoprotein (labeled as HIV vector) were used as back-
ground controls, giving low levels of luciferase activity
(2.7 to 3.1 logs of RLUs). The cells incubated with the
VSV-G/HIV virions were used as positive controls (6.6 to
7.3 logs of RLUs), consistent with the fact that VSV-G can
mediate efficient viral entry in a very broad range of cell
types. The four cell lines incubated with the HA(QH)/HIV
pseudovirions gave levels of luciferase activity from
approximately 10- to 100-fold higher than the back-
ground levels depending on the cell types (4.3 to 5.1 logs
of RLUs), indicating that these cell lines, both human and
avian origins, can be infected by the HA(QH)/HIV pseu-
dovirions.Virology Journal 2009, 6:39 http://www.virologyj.com/content/6/1/39
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Neuraminidase treatment of the producer cells 
enhancesHA-mediated viral infectivity
To improve and optimize the HA-mediated transduction
efficiency, a commercially available neuraminidase,
which catalyzes hydrolysis of α2,3, α2,6, and α2,8 linked
N-acetyl-neuraminic acid residues from glycoproteins and
oligosaccharides, was used to treat the transfected 293T
producer cells twice at 26 and 46 hours post-transfection
with ramping concentrations of 0, 5, 10, 20, 50, 100, and
200 units/ml. The collected viral supernatants were used
to challenge susceptible target cells, 293T and A549 cells
(a human lung cell line, see below), and the luciferase
activities of the target cells were determined at 48 hours
post-infection (Fig. 1B). The target cells challenged with
the viral supernatants collected from the neuraminidase-
treated producer cells, even at the lowest concentration
used (5 units/ml), gave luciferase activities at least 10-fold
higher than the same target cells challenged with the
supernatants from the non-treated producer cells (5.21 vs
4 logs in 293T cells, and 4.49 versus 3.43 logs in A549
cells, respectively). The viral supernatants collected from
the producer cells treated with higher concentrations of
neuraminidase (10–200 units/ml) could further boost the
luciferase signals in the target cells, up to approximately
another 10-fold with the highest concentration used (5.21
vs 6.04 logs in 293T cells, and 4.49 vs 5.93 logs in A549
cells, respectively). We can now routinely achieve approx-
imately 1,000-fold of the luciferase signal over the back-
ground in the HA-mediated transduction of the target
cells (both 293T and A549 cells) by neuraminidase treat-
ment to the producer cells. Thus, the HA(QH)/HIV pseu-
dovirions (see below) used for subsequent experiments
were generated using the commercially purchased neu-
raminidase to treat the 293T producer cells to improve
transduction efficiency.
HA-mediated transduction is sensitive to 
lysosomotropicagents
To test pH-dependence of the HA-mediated transduction,
the sensitivity of HA/HIV virions to lysosomotropic
agents was examined on 293T target cells. The target cells
were first treated with either ammonium chloride
(NH4Cl) or Bafilomycin A1 at different concentrations
(see Materials and Methods for the details) prior to incu-
bation with the HA(QH)/HIV pseudovirions, and the
infected cells were assayed for luciferase activity 48 hours
post-infection. As shown in Fig. 2, both NH4Cl and Bafilo-
mycin A1 could greatly inhibit the HA(QH)-mediated
transduction efficiency. As controls, the HIV glycoprotein
gp120/gp41-mediated transduction, which was previ-
ously shown to be pH-independent[24,25], was not
adversely affected by either compounds, while the Ebola
GP-mediated transduction, a pH-dependent virus[19,21],
was severely inhibited by both compounds. These results
A. Establishment of the HA(QH)-mediated transduction  assay and optimization of the HA(QH)-mediated transduc- tion by neuraminidase treatment Figure 1
A. Establishment of the HA(QH)-mediated transduc-
tion assay and optimization of the HA(QH)-medi-
ated transduction by neuraminidase treatment. The 
HA(QH)/HIV, VSV-G/HIV and HIV alone (no Env) pseudovir-
ions were generated in 293T producer cells as described in 
Materials and Methods. These virions were separately incu-
bated with the target cells (293T, HeLa, QT6, and DF-1), and 
the luciferase activity of each infected cell line, represented 
as log (relative luciferase units, or RLUs), was determined 48 
h post-infection. HIV vector (no Env), background controls, 
VSV-G/HIV, positive controls. Values are means of triplicate 
samples ± SD. B. The HA(QH) plasmid were first co-trans-
fected with the HIV vector to 293T producer cells, and the 
transfected cells were treated with a commercial neuramini-
dase at various concentrations (0, 5, 10, 20, 50, 100, and 200 
units) at 26 h and 46 h post-transfection. The generated 
pseudovirions were collected at 48 h post-transfection and 
used to challenge the target cells (293T and A549), and the 
luciferase activities of the infected cells were determined 48 
h post-infection. HIV vector (no EnV), background controls, 
VSV-G/HIV, positive controls. Values are means of triplicate 
samples ± SD.Virology Journal 2009, 6:39 http://www.virologyj.com/content/6/1/39
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are consistent with the notion that entry of H5N1, like
that of other influenza viruses[10,26], is pH-dependent.
Multiple human cell lines are susceptible to HA-mediated 
viral infection
To characterize and compare the host tropism at the entry
step for H5N1, the HA(QH)/HIV pseudovirions were
incubated with numerous cell lines derived from different
species and tissues and the transduction efficiencies were
measured as the relative levels of luciferase activity (RLUs)
in the challenged cells (Table 1). In these experiments, the
VSV-G-mediated HIV pseudovirion transduction was used
as a positive control since VSV-G displays a very broad
host range. Among the 17 cell lines examined (Table 1),
all were highly susceptible to VSV-G pseudovirus infection
as indicated by greater than 106 RLUs with the only excep-
tion being A20, a mouse B lymphocytes-derived cell line,
which gave only approximately 10-fold higher luciferase
activity when challenged with the VSV-G/HIV (2.3 × 104
RLUs) over the HIV vector alone (2.4 × 103 RLUs), sug-
gesting a possible post-entry block for HIV in this cell line.
The remaining sixteen cell lines gave high luciferase activ-
ities of more than 6 logs of RLUs when challenged with
the VSV-G/HIV virions, ranging from about 100- to more
than 1000-fold over the background levels (cell alone or
HIV vector alone), indicating there is no post-entry block
for HIV infection in these cells. Thus, the relative levels of
RLUs of these cells challenged with the HA(QH)/HIV vir-
ions indicate the transduction efficiencies of the cells by
the HA protein.
Sensitivity of the HA-mediated transduction to lysosomo- tropic agents Figure 2
Sensitivity of the HA-mediated transduction to lyso-
somotropic agents. The 293T target cells were first 
treated with either ammonium chloride (NH4Cl) or Bafilo-
mycin A1 (BAF) at various concentrations prior to the chal-
lenge by the HA(QH)/HIV, Ebola GP/HIV, and HIVgp120/41/
HIV (labeled as GP120/HIV here) pseudovirions. The luci-
ferase activities of the infected cells were determined 48 h 
post-infection. The data of the NH4Cl treatment at the con-
centration of 3.125 mM and the Bafilomycin treatment at the 
concentration of 3.125 nM are shown here. Values are means 
of triplicate samples ± SD.
Table 1: Transduction of cell lines from different species
RLUs
Name of cell line Cell type Cell alone HIV vector HIV
(VSV-G)
HIV(HA)
(QH)
293T Hua, kidney 3.5 × 102 4.8 × 103 4.8 × 106 2.4 × 106
A549 Hu, lung 5.5 × 102 5.9 × 103 3.1 × 106 1.1 × 106
HeLa Hu, cervical carcinoma 5.3 × 102 4.1 × 103 1.2 × 107 2.0 × 104
SAOS-2 Hu, bone 5.4 × 102 2.2 × 103 9.2 × 106 6.0 × 104
HepG2 Hu, liver 5.0 × 102 1.8 × 103 4.6 × 106 3.1 × 104
Huh 8 Hu, liver 5.3 × 102 6.5 × 104 1.4 × 107 8.1 × 106
Jurkat Hu, T lymphocyte 1.0 × 103 1.7 × 103 1.5 × 107 2.1 × 103
QT6 Quail, fibrosarcoma 6.1 × 102 3.4 × 103 1.7 × 107 3.9 × 104
DF-1 Chicken, embryo 5.1 × 102 3.5 × 103 1.6 × 107 4.4 × 104
CHO CHb, ovary 5.1 × 102 3.4 × 103 4.6 × 106 4.1 × 103
Lec 1 CH, ovary 6.2 × 102 2.1 × 103 1.6 × 107 1.6 × 103
Vero E6 AGMc, kidney 4.8 × 102 2.0 × 103 4.7 × 106 9.5 × 103
COS-7 AGM, kidney 5.4 × 102 1.0 × 103 1.1 × 107 2.7 × 103
3T3 Mouse, kidney 6.6 × 102 1.5 × 103 1.7 × 107 1.7 × 103
RAW264.7 Mouse, macrophage 5.6 × 102 2.2 × 103 1.7 × 107 1.6 × 103
A20 Mouse, B lymphocyte 5.3 × 102 2.4 × 103 2.3 × 104 2.6 × 104
MDBK Cow, kidney 7.0 × 102 3.2 × 103 1.8 × 107 2.3 × 103
a. Hu, Human.
b. CH, Chinese hamster.
c. AGM, African green monkey.Virology Journal 2009, 6:39 http://www.virologyj.com/content/6/1/39
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The sixteen cell lines can be roughly classified into three
different groups, susceptible, moderately susceptible, and
resistant to the HA-mediated transduction. The suscepti-
ble cells include 293T, A549, and Huh8, all of which were
derived from human tissues. These cells, when challenged
with HA(QH)/HIV virions, gave luciferase levels of
roughly 100–1000-fold higher than the background con-
trols (106-107  RLUs  vs  103-104  RLUs with HIV vector
alone). HeLa (human), HepG2 (human), SAOS2
(human), Vero E6 (African green monkey), and two avian
cell lines (QT6, quail, and DF-1, chicken) are moderately
susceptible to the HA-mediated transductions, giving
approximately 5–10 fold higher RLUs than the HIV alone
controls. The other seven cell lines from different species
(CHO, Lec1, COS-7, MDBK, Jurkat, 3T3, and RAW264.7)
were resistant to the HA-mediated transductions under
the experimental conditions (Table 1).
Human lung cell lines are susceptible to HA-
mediatedtransduction
To investigate whether the lung cells were susceptible to
HA-mediated transduction, we obtained and tested three
more lung cell lines in addition to A549 cells: NCI-
H661(human), HPAEC (human), and L2 (rat), and the
results are summarized in Table 2. Transduction efficien-
cies are representative of repeated experiments displaying
similar trends. In these experiments, Lec 1 cells were used
as a negative control since previously Lec 1 was shown to
be resistant to influenza viral entry by others[27] and us
in this report (see Table 1). Like A549, NCI-H661 could
be efficiently transduced by HA(QH)/HIV (100–1,000
fold higher of RLUs than the background). HPAEC could
be transduced at a lower efficiency (more than 10-fold
higher of RLUs than the background). In contrast, the rat
lung L2 cells were relatively resistant to transduction by
HA(QH). It should be pointed out that all of these results
were visually confirmed using an HIV vector carrying a
GFP as the reporter gene under a microscope (data not
shown). These results demonstrated that human lung
cells, but not rat lung cells, are susceptible to HA-medi-
ated transduction.
Relative levels of cell surface sialic acids do not 
correlatewith the HA(QH)-mediated entry
To better understand the role SA plays in transduction
mediated by HA(QH), we sought to determine the overall
relative abundance of 2,3 and 2,6SA linkages on 13 cell
lines previously tested in the transduction assay, however
glycan topology nor sulfation or fucosylation were able to
be assessed using this system. Cell lines were chosen based
on their species and tissue origin as well as on transduc-
tion levels. Utilizing fluorescently conjugated lectins
which bind specifically to either 2,3SA (MAA TRITC) or
2,6SA (SNA-I FITC), equal number of cells were incubated
with each lectin for 15 minutes in the dark. Cells were
then washed 3 times with PBS, resuspended, and analyzed
via FACS to determine relative sialic acid levels. 293T
(human kidney), A549 (human lung), NCI-H661
(human lung), HeLa (human cervical carcinoma), Huh8
(human liver), and Jurkat (human T lymphocyte) cell
lines all demonstrated high levels of the human influenza
receptor, 2,6SA, at levels of 700–1,600 with NCI-H661
cells having a modest level of more than 400, while CHO
(Chinese hamster ovary), DF1 (chicken embryo), and
QT6 (quail fibroblast) cell lines all had at least 5-fold
lower levels (Fig. 3). DF1, NIH 3T3, Jurkat, and A549 cells
had greater levels of 2,3SA compared to the other cells
tested. A comparison between transduction levels and
either 2,3SA or 2,6SA reveals that there is no correlation
between either receptor level or the level of entry. The
human lung cell line, A549, and the HeLa cell line have
similar profiles for both 2,3SA and 2,6SA, however A549
cells are susceptible to H5N1 HA-mediated transduction
while HeLa cells are not, suggesting that the overall level
of either 2,3SA or 2,6SA does not correlate with H5N1-HA
mediated transduction. Thus, we do not see a correlation
between the levels of either 2,3, or 2,6 SA receptor and the
HA-mediated transduction, suggesting a possible role of a
co-factor in H5N1 entry either in conjunction with or per-
haps independently of sialic acid.
Mutational analysis of the H5N1 HA receptor binding 
domain
The receptor binding domain of hemagglutinin (HA) has
been well characterized and studied with respect to key
amino acids which are responsible for mediating attach-
ment of the viral glycoprotein to its receptor, sialic acid
[28-31]. These studies have defined which amino acids
within this domain mediate attachment to 2,3SA as well
as what amino acid mutations switch binding to 2,6SA. In
the H1 serotypes, the single amino acid change at position
190 from glutamic acid (E) to aspartic acid (D) is crucial
for the virus to adapt to usage of the human 2,6SA recep-
tor. For the H2 and H3 serotypes, two amino acid altera-
tions are required. A switch of glutamine (Q) to leucine
(L) at position 226 and a switch of glycine (G) to serine(S)
at position 228 equates a shift from avian receptor to
Table 2: Transduction of different lung cell lines
RLUs
Name of cell line Cell type HIV vector HIV
(VSV-G)
HIV(HA)
(QH)
A549 Hua, lung 2.3 × 103 3.1 × 106 1.7 × 106
NCI-H661 Hu, lung 1.8 × 103 3.0 × 106 2.1 × 106
HPAEC Hu, lung 7.2 × 103 1.7 × 107 7.6 × 104
L2 Rat, lung 2.3 × 103 6.8 × 106 5.1 × 103
Lec 1 CHb, ovary 1.9 × 103 1.7 × 107 2.5 × 103
a. Hu, Human.
b. CH, Chinese hamster.Virology Journal 2009, 6:39 http://www.virologyj.com/content/6/1/39
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human receptor specificity. In addition the following res-
idues have been implicated in altering sialic acid binding
including H183F andL194A. Further studies specifically
targeted towards the HA of the A/Vietnam/1203/2004
H5N1 virus demonstrated the importance of mutation
E190D reduced the binding to 2,3SAs, as well as the dou-
ble mutant Q226L/G228S. Together these studies strongly
suggest that residues 190, 226 and 228 are crucial for sialic
acid binding and in fact, determine the preference for
either 2,3SA or 2,6SA.
To further examine the entry tropism mediated by HA, we
generated mutations targeted to residues within the recep-
tor binding domain that have been previously implicated
in altering SA binding preference. Using site-directed
mutagenesis, we created the following mutations within
the H5N1 HA codon optimized backbone: H183F,
E190D, L194A, Q226L, G228S, and Q226L/G228S. All
mutations were confirmed through sequencing. Western
blot analysis of viral particles showed similar levels of HA
incorporation for each substitution as well as similar over-
all levels of viral particle production as measured by p24
levels (data not shown).
Viral pseudotypes were generated as previously men-
tioned, however, co-transfection of the neuraminidase
gene, (A/Puerto Rico/8/34(H1N1)), along with our luci-
ferase reporter and HA gene, allowed viral egress to occur
and alleviated the need to treat producer cells with exoge-
nous purified neuraminidase. Target cell lines, 293T (data
not shown) and A549, had comparable levels of 2,3SA
and 2,6SA, suggesting that mutations generated in the HA
protein should affect viral entry in these cell lines in a sim-
ilar manner. Each HA pseudovirus with or without any
substitutions gave luciferase levels of 106–107 units while
still remaining within the linear range of the assay. The
Analysis of relative surface levels of 2,3 and 2,6 sialic acid Figure 3
Analysis of relative surface levels of 2,3 and 2,6 sialic acid. Relative surface levels of 2,3 and 2,6 sialic acid in different 
cell lines as measured using the fluorescently conjugated lectins 2,3 sialic acid specific MAA-TRITC and 2,6 sialic acid specific 
SNA-I-FITC. Data is representative of repeated experiments displaying similar trends. Values are means of triplicate samples ± 
SD.Virology Journal 2009, 6:39 http://www.virologyj.com/content/6/1/39
Page 7 of 13
(page number not for citation purposes)
mutation E190D which has been shown to decrease affin-
ity of the H5N1 HA for 2,3SA did not alter transduction of
either cell line dramatically as represented by RLUs in
A549 cells (Fig. 4B). Mutations Q226L/G228S which have
also been implicated in decreasing affinity towards 2,3SA
showed little affect in infectivity. None of the other muta-
tions implicated in altering the binding properties of
hemagglutinin for sialic acid showed a dramatic differ-
ence in transduction levels either. These results indicate
that these substitutions did not greatly alter the HA-medi-
ated transduction, consistent with the notion that a cofac-
tor may be involved in H5N1 entry or that an alternate
linkage of sialic acid is necessary.
Binding analysis of the recombinant HA1 proteins to 
thetarget cells
A cell-based binding assay was developed to examine the
binding properties of a number of recombinant WT and
mutant HA1 proteins. First, four constructs of HA1 frag-
ments fused with a human IgG Fc were generated (Fig.
5A). These four fusion proteins were transiently expressed
in 293T cells and the secreted fusion proteins in the super-
natants were purified following a published protocol. The
purified proteins were resolved by SDS-PAGE followed by
Coomassie staining (Fig. 5B). The purified HA17–340,
HA17–268, and HA89–268 each displayed a predominant
band corresponding to ~90, 80, and 60 kDa, respectively
(lanes 2, 3, and 4). In contrast, HA89–340 had two major
bands: a band of about 70 kDa and a smaller band around
35 kDa (lane 5).
The purified proteins were used to evaluate their binding
properties to 293T cells which are permissive to the HA-
mediated transduction. Neither HA17–268 nor HA89–268,
with the amounts of proteins used here, displayed much
binding to the target cells, which was measured by flow
cytometry (Fig. 5C). In contrast, HA17–340 and especially
HA89–340showed a dose-dependent binding to the target
Effect of hemagglutinin receptor-binding domain mutations in viral entry Figure 4
Effect of hemagglutinin receptor-binding domain mutations in viral entry. (A) Sequence alignment of mutations gen-
erated. (B) Relative infectivity of pseudoviruses containing specified receptor-binding domain substitutions as measured by luci-
ferase activity. Data is representative of repeated experiments displaying similar trends. Values are means of triplicate samples 
± SD.Virology Journal 2009, 6:39 http://www.virologyj.com/content/6/1/39
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cells. To further confirm this finding, 2 μg of each protein
was used to bind three cell lines including 293T. As shown
in Fig. 5D, HA89–340 displayed binding to both 293T and
HeLa cells, both of which are permissible to the HA-medi-
ated transduction, while it did not show any binding to
Jurkat cells, a non-permissive cell line. The other three
fusion proteins did not give detectable binding under this
condition. Thus the following experiment was done using
HA89–340.
To examine the potential effect of residue substitutions of
HA on cell binding, the following mutant constructs were
generated using HA89–340as the backbone: E190D, and
L194A. These proteins were purified as described above
and the purified proteins were examined by SDS-PAGE
followed by Coomassie staining (Fig. 6A). The wt and
substitution mutants showed the same two bands, a large
band of about 70 kDa and a small band of about 35 kDa.
These proteins were used to bind both 293T and A549
cells as described in Materials and Methods. Although it
appears that mutant E190E displayed slightly higher bind-
ing to the target cells, these substitution mutants in gen-
eral did not cause a major difference in cell binding
compared to that of wt, as measured by relative mean flu-
orescence intensity (MFI) (Fig. 6B). These results are in
agreement with that of the transduction data presented
above, implicating a potential cofactor on the target cells
which is involved in HA binding.
Discussion
Different pseudotyping systems have been developed in
dissecting the roles of the glycoproteins of highly patho-
genic enveloped viruses such as Ebola virus in viral entry
and host tropism. To date, such systems have not been
used often in entry studies of influenza viruses, although
several groups have previously shown the feasibility of
this technique in applications such as vaccine develop-
ment and gene targeting using various viral vectors [32-
37]. In this report, we have developed an efficient HIV-
based pseudotyping system for avian influenza H5N1 to
Cell binding of purified HA.hIgG proteins Figure 5
Cell binding of purified HA.hIgG proteins. (A) Diagram of HA.hIgG constructs. SP, signal peptide. (B) Coomassie staining 
of purified HA.hIgG proteins resolved by SDS-PAGE. (C) Binding of the purified HA.hIgG to 293T cells. Different amounts of 
proteins were used to bind 293T cells and the binding was measured by flow cytometry as described in Materials and Methods. 
Relative mean fluorescent intensity (MFI) was calculated by deducting MFI of negative control (no purified protein added) from 
that of cells incubated with purified proteins. (D) Binding of 2 μg purified proteins to three different types of cells.Virology Journal 2009, 6:39 http://www.virologyj.com/content/6/1/39
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circumvent the strict requirements in handling this highly
pathogenic virus. We anticipate that this system will be
invaluable for screening and developing potential entry
inhibitors against H5N1. In addition, this pseudotyping
system can be easily adapted for entry studies of 1918
Spanish flu and other highly pathogenic influenza viruses
with alleviated safety concerns.
Multiple viral factors including HA, NA, the polymerase
complex, and NS1 have been implicated in determining
the cell and host tropism of influenza viruses [12,13,38-
42]. Among them, HA is known to be one major determi-
nant which dictates the host restriction [12,43,44]. One of
the applications of viral pseudotyping systems such as the
one developed for H5N1 in this report is to distinguish
the host restriction at the entry step determined by HA
from those restrictions at the post-entry steps determined
by other viral proteins. Here, we demonstrate that several
salient features of HA have been recapitulated by the HIV-
based pseudotyping system in this report. First, efficient
HA-mediated transduction is dependent on neuramini-
dase treatment on the producer cells (see Results and Fig.
1B), consistent with the notion that NA is involved in
cleaving the sialic acid (SA) and thus releasing the bud-
ding viral progeny from the cell surface [45]. Furthermore,
neuraminidase treatment can be replaced by cotransfec-
tion of a human N1 NA gene with the HA gene and HIV
vector. It is likely that the HA-mediated transduction effi-
ciency reported in this study, even though very efficient
already, can be further optimized by co-expressing M2 in
Effect of HA substitutions Y105F, E190D and L194A on cell binding Figure 6
Effect of HA substitutions Y105F, E190D and L194A on cell binding. (A) Coomassie staining of the wt and mutant 
HA89–340 proteins resolved by SDS-PAGE. (B) Binding of wt or mutant HA proteins to 293T or A549 cells.Virology Journal 2009, 6:39 http://www.virologyj.com/content/6/1/39
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293T producer cells since others have shown a synergy of
M2 and NA in viral particle release [37]. Second, it is well-
documented that influenza viruses enter the host cells via
receptor-mediated endocytosis in a pH-dependent man-
ner [26]. The sensitivity of HA(QH)-mediated transduc-
tion to both lysosomotropic agents demonstrated the
strict requirement of low pH for the pseudoviral infection
to the target cells (see Fig. 2). Together these results give
compelling arguments for using HA/HIV pseudotyping as
a simple and reliable surrogate system in elucidating the
host tropism of H5N1 and other highly pathogenic influ-
enza viruses at the entry step.
In this report, we have examined the cell tropism of a
highly pathogenic avian influenza virus H5N1, which was
originally isolated from the infected migratory birds in
Qinghai Lake of Western China [16], at the entry step. The
surprising finding is that the most susceptible cell lines for
the HA(QH)-mediated transduction are those derived
from humans, 293T (kidney) and Huh 8 (liver), and all of
the human lung cell lines tested, A549 and NCI-H661
consistent with the recent reports that H5N1 virus can
attach to the lower respiratory tract and lung of humans
[46,47]. In stark contrast, two avian cell lines, QT6 (quail
fibroblasts) and DF-1 (spontaneously immortalized
chicken embryo fibroblasts), were transduced by
HA(QH)/HIV virions at much lower frequencies (see
Tables 1 and 2). These results indicate that this highly
pathogenic H5N1 virus can enter numerous human cells
including those derived from human lungs more effi-
ciently than that in the two avian cell lines, suggesting that
the HA protein of H5N1 can effectively interact with the
cognate cellular receptor(s) on human cells to initiate
viral infection. Furthermore it appears that other viral
and/or human determinants, rather than HA, restrict effi-
cient transmission of H5N1 to humans in a sustained
manner. Therefore we believe that while the H5N1 virus
still needs to acquire the ability, either through mutations
or genomic re-assortment or both, to produce sustained
infection in humans, it appears that this final step for the
virus to overcome is at the post-entry level.
Another important implication of the current study is that
either an unidentified host co-factor or an alternate link-
age of sialic acid may be necessary for mediating H5N1
entry and infection. It is well documented that avian influ-
enza viruses preferentially bind to sialic acid (SA) recep-
tors on avian cells where the SA is predominantly joined
to the sugar chain through an α2–3 linkage, while
human-adapted influenza viruses have an increased affin-
ity to the SA receptors of the α2–6 linkage [10], a major
form in the human respiratory tract. It is believed that a
switch in preferential receptor-binding from the α2–3
linked SA to the α2–6 linked SA by HA protein is a prereq-
uisite for an avian influenza virus to emerge as a pandemic
threat in human populations [12]. Recently it was sug-
gested that in addition to the SA linkages, glycan topology
as well as sulfation and fucosylation can dictate human
adaptation of avian H5N1 virus HA [48]. The question is
why the HA protein of H5N1, an avian influenza virus,
can transduce human cells more efficiently than non-
human cells including avian cells. It is possible that accu-
mulated mutations in the receptor binding domain
(RBD) have increased the binding affinity of HA(QH) to
the α2–6 linked SA receptors on the human cells. Struc-
tural and binding studies of a closely related HA (A/Viet-
nam/1203/2004, or Viet04 HA) in a recent report are
somewhat consistent with this notion. It was found that
Viet04 HA is more related to the 1918 and other human
HAs than to a 1997 duck H5 HA (DK97 HA) and there are
only two noticeable substitutions in the conserved resi-
dues of RBDs, E216 and P221 in DK97 HA vs R216 and
S221 in Viet04 HA. Viet04 HA was shown to bind α2–6
glycans with some affinity, while DK97 HA did not dis-
play any binding [49]. Since the corresponding residues in
HA(QH) are K216 and S221 at these positions, it can be
assumed that HA(QH), just like Viet04 HA, can bind the
α2–6 SA receptors on the human cells to initiate viral
entry. However, Viet04 HA was shown to bind to the α2–
3 glycans with higher affinity than the α2–6 glycans [49],
which is most likely true for HA(QH). At the same time,
HA(QH) is able to mediate more efficient transduction in
human cells than avian cells. Further, there is no obvious
correlation between the HA-mediated transduction effi-
ciency and the surface levels of 2,3 or 2,6 SAs displayed by
several cell lines, and HA substitutions of the SA-binding
residues do not greatly impact the HA-mediated transduc-
tion or target cell binding. It is possible that an alternative
linkage of sialic acid, such as 2,8 or 2,9, may play a role in
mediating viral attachment and entry. Here we propose
that SA is necessary, but not sufficient to act as the cellular
receptor and another surface molecule (or molecules) in
addition to SA is also required to mediate efficient H5N1
entry. Indeed it was reported that SA specificity of avian
influenza viruses may not restrict initial avian-to-human
transmission [50]. Although no such molecule(s) has
been identified up to date, a recent report indeed suggests
that a host N-linked glycoprotein is required for human
influenza virus entry [27]. Therefore, a similar (or differ-
ent) protein on the human cells such as A549 can act as
the co-factor in mediating efficient H5N1 entry, while the
same protein on the avian cells is not as efficient as the co-
factor either due to a low level of surface expression or low
binding affinity to HA. In contrast, the resistant cells such
as L2 (rat lung), Lec 1 (Chinese hamster ovary), or Jurkat
(human T lymphocyte) may not express a functional
homolog on the cell surface. This conclusion is in agree-
ment with a recent report that human tissues lacking the
SA receptor can be infected with H5N1 viruses [51].Virology Journal 2009, 6:39 http://www.virologyj.com/content/6/1/39
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Finally, it is important to emphasize that the HIV-based
pseudotyping system, together with the numerous suscep-
tible and resistant cell lines and a functional recombinant
HA protein reported in this study, will greatly facilitate
identification of the co-factor(s) for H5N1 and likely
other influenza viruses by genetic and biochemical tech-
niques. Identification and characterization of such host
co-factor(s) will have a huge impact on our understanding
of the host restriction of H5N1 and on development of
potential therapeutics against H5N1 pathogenicity.
Methods
Plasmids and cell lines
HA (QH) gene is from a highly pathogenic H5N1 influ-
enza virus in goose (Goose/Qinghai/59/05)[16]. HA
(QH) and HA (codon optimized) were cloned into
pcDNA3 and sequences were confirmed. T4-pMV7 and
pc-CCR5 were from the National Institute of Health AIDS
Research and Reference Reagent Program. NA (A/PR/8/
34) influenza virus (H1N1) in the vector pEF6/V5-His-
TOPO was kindly provided by John C Olsen (University
of North Carolina, Chapel Hill, USA).
The following cell lines were either purchased from ATCC
or provided by other investigators: Vero E6, MDBK, NCI-
H661, L2, and Lec1 (ATCC); SAOS-2 and RAW264.7(Bin
He, University of Illinois at Chicago), A549 (James Cook,
University of Illinois at Chicago), HPAEC (Chinnaswamy
Tiruppathi, University of Illinois at Chicago, USA), and
DF-1 (Douglas Foster, University of Minnesota, USA). The
rest of the cell lines used in the study are maintained in
the laboratory. All cell lines were maintained in medium
according to the protocols supplemented with 10% FBS
and penicillin/streptomycin (50 units/ml).
Antibodies
The rabbit polyclonal antibody ab21297, which recog-
nizes 14 amino acids within residues 100–150 of avian
influenza A (H5N1) hemagglutinin protein, was pur-
chased from Abcam Inc. The mouse anti-HIV p24 mono-
clonal antibody was obtained from the National Institute
of Health AIDS Reseach and Reference Reagent Program,
which was used to estimate the levels of HIV particle pro-
duction as measured by p24 levels using Western blotting.
Production of HIV pseudovirions
Human embryonic kidney 293T cells were transiently co-
transected with 8 μg hemagglutinin envelope expression
plasmid with or without 0.5 μg NA and 10 μg Env-defi-
cient HIV vector (pNL4.3.Luc-R-E- or pNL4-3-GFP-R-E-) in
100-mm plates by a standard Ca3(PO4)2 protocol. Sixteen
hours post-transfection, cells were washed by phosphate-
buffered saline (PBS) without Ca2+, Mg2+, 10 ml fresh
medium was added into each plate. Forty-eight hours
post-transfection, the supernatants were collected and fil-
tered through a 0.45-μm-pore size filter (Nalgene) and the
pseudovirions were directly used for infection.
Infection assay of HIV pseudovirions
The HIV pseudovirions (0.5 ml/well) prepared above
were incubated with various cell types, seeded at 5 × 104/
well in 24-well plates. For HIV-Luc virions, the targeted
cells were lysed in 50 μl of cell culture lysis reagent
(Promega) 48 h post-infection. The luciferase activity was
measured with a luciferase assay kit (Promega) and an
FB12 luminometer (Berthold detection system) according
to the supplier's protocols. The experiments were repeated
three times. For HIV-GFP virions infection, the targeted
cells were observed by fluorescence microscopy.
Neuraminidase treatment
The 293T producer cells were treated with a commercial
neuraminidase (New England Biolabs) 26 h and 46 h
post-transfection at concentrations of 0, 5, 10, 20, 50,
100, 200 units/ml to optimize the yield of HIV pseudovir-
ions, and later on at 100 units/ml for generation of pseu-
dovirions. Pseudovirions were harvested 48 h post-
transfection.
Detection of HA incorporation in pseudotyped viruses
To examine incorporation of HA(QH) to HIV particles, 4
ml of the collected supernatant was layered onto a 1.5-ml
cushion of 20% sucrose (wt/vol) in PBS and centrifuged at
55,000 rpm for 45 min in a Beckman SW55 rotor. The pel-
leted HIV virions were lysed in 40 μl of Triton X-100 lysis
buffer(50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 5 mM
EDTA, 1% Triton X-100, and a protease inhibitors cocktail
consisting of 10 μg of leupeptin per ml, 5 μg of aprotinin
per ml, and 2 mM phenylmethylsufonyl fluoride), and a
35 μl sample was subjected to sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and
transferred to a polyvinylidene difluoride membrane. The
membrane was first incubated with anti-H5N1 HA1 poly-
clonal antibody ab21297(1:500) for 1 h and then probed
with peroxidase-conjugated goat anti-rabbit antiserum
(Pierce) for 40 min. The bands were visualized by the
chemiluminescence method according to the protocol of
the supplier (Pierce). In these experiments, HIV p24 level
was determined by Western blotting as an estimate for the
relative amounts of the pseudovirions.
NH4Cl and Bafilomycin A1 treatment
Cells were treated with 3.125, 6.25, 12.5, 25, and 50 nM
Bifilomycin A1 (BAF) (Sigma) or 3.125, 6.25, 12.5, 25,
and 50 mM ammonium chloride (NH4Cl) 30 min prior to
infection. For the infection of the HIV envelope (gp120/
gp41) pseudotyped HIV virions, 293T cells were first co-
transfected with T4-pMV7 and pc-CCR5 36 h prior to
infection.Virology Journal 2009, 6:39 http://www.virologyj.com/content/6/1/39
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Lectin Binding Assay
5 × 105 cells (293T, A549, NCI-H661, HeLa, L2, CHO,
DF1, and QT6) were washed with PBS, pelleted, and
resuspended in phosphate-buffered saline. Each cell type
was incubated independently with 100 μg/mL of fluoro-
chrome-conjugated lectins, Maackia amurensis agglutinin
(MAA)-TRITC and Sambucus nigra agglutinin (SNA)-FITC
(EY Laboratories) for 15 minutes in the dark. Cells were
then washed 3 times with PBS and analyzed by flow
cytometry.
Receptor-binding Domain Mutagenesis
Mutations were generated in the codon optimized HA
backbone using a Site-Directed Mutagenesis Kit (Strata-
gene) and custom primers.
Fusion Protein Production and Purification
To study HA binding to the target cells, plasmids encoding
HA fusion protein (different fragment of HA fused to Fc of
human IgG) were constructed and the fusion proteins
were purified. NheI-BamHI fragment of S1.hIgG was
replaced with the PCR product of different fragments of
the codon optimized HA gene. Plasmids of HA.hIgG were
tranfected into 293T cells using the calcium phosphate
method. After overnight, cells were re-fed with protein-
free VP-SFM media supplemented with 4 mM L-glutamine
(Gibco). Supernatants were collected twice at 48 and 72
hours post-tranfection and filtered through 0.45 μM
membrane (Millipore). The supernatants were applied to
a column of protein A beads (Santa Cruz Biotechnology)
followed by three washing with 10 ml PBS. The proteins
were eluted three times with 1 ml 0.1 M glycine (pH 2.8)
and immediately neutralized with 60 μl Tris-HCl (pH8.0)
each time. Then the proteins were dialyzed in 3.5K Slide-
A-Lyzer Dialysis Cassettes (Pierce) and concentrated by
centrifuging in YM-10 Centricon (Millipore). The protein
concentrations were measured using the BCA Protein
Assay Kit (Pierce).
Cells (5 × 105 293T or A549) were blocked in 500 μl vol-
ume of PBS/1%BSA on ice for 0.5 hour. Then different
amounts of the purified proteins were incubated with
cells in 500 μl volume of PBS/1%BSA on ice for 1.5 hour.
Cells were incubated with no purified proteins as a nega-
tive control. Next the cells were washed twice with PBS/
1%BSA and incubated with anti-human antibody conju-
gated with FITC (1:100 dilution, Sigma) in 500 μl volume
of PBS/1%BSA on ice for 40 minutes. Then cells were
washed three times with PBS/1%BSA followed by one
washing with PBS and subjected to flow cytometry. Rela-
tive mean fluorescent intensity (MFI) was calculated by
subtracting MFI of the negative control from MFI of cells
incubated with different purified proteins.
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